D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

NAMS holding history

NewAmsterdam Pharma Co N.V. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NAMS overview All 13F holders of NAMS Full Q2 2026 holdings

Shares (Q2 2026): 120,561
Value: $4.09M
% of portfolio: <0.1%
Quarters held: 2; Since Q3 2024

Holdings of NAMS by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	120,561	$4.09M	<0.1%	+120,561	New	Holders
Q4 2024	0	$0	0.0%	−18,345−100.0%	Sold out	Holders
Q3 2024	18,345	$304.5K	<0.1%	+18,345	New	Holders